Acutus Medical expands AFib offerings; announces strategic acquisition and new partnerships in monitoring and therapy

Clean Sweep Live Auction on Wed. Sept. 23rd. Click to see the full inventory

Acutus Medical expands AFib offerings; announces strategic acquisition and new partnerships in monitoring and therapy

Press releases may be edited for formatting or style | May 10, 2019 Cardiology
SAN FRANCISCO, May 9, 2019 /PRNewswire/ -- Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfolio builds on the organization's unprecedented mapping and visualization technology platform. Acutus is committed to helping electrophysiologists improve patient outcomes and reduce AFib burden by delivering world-class cardiac access, novel arrhythmia diagnostics, innovative therapies and wireless multi-channel monitoring.

"At Acutus, we are challenging the status quo by building a suite of next generation products on an open platform that improves EP lab efficiency and effectiveness," said Acutus Medical CEO Vince Burgess. "Our dynamic business model addresses the entire patient care continuum and is elevating electrophysiology. We are positioned to become the only focused arrhythmia care company with a complete suite of solutions that electrophysiologists need to diagnose, treat and follow patients with atrial arrhythmias."

The Rhythm Xience acquisition and partnership agreements create a foundation for Acutus to provide solutions spanning access, therapy, diagnostics and rhythm monitoring:

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

Access Sheaths and Introducers
Acutus is acquiring Rhythm Xience, known for its integrated family of highly novel and user-friendly transseptal crossing and steerable introducer systems. This acquisition expands Acutus' ability to improve access and effectively treat arrhythmias with: Flextra, a two-way steerable introducer sheath; Guider, a fixed curve introducer and Lancer, a transseptal crossing device. All products are FDA cleared and commercially available.

To ensure early detection as well as to validate treatment efficacy, Acutus has partnered with Peerbridge Health to offer the most advanced ambulatory ECG, The Peerbridge Cor™. The Peerbridge system offers the only truly wireless multi-channel ECG monitor that is FDA cleared to detect up to 26 different arrhythmias. The system records every heartbeat for up to seven days and can transmit patient activated events via the cloud, ensuring accelerated arrhythmia detection by clinical staff. At the end of each test, a quantitative analysis and AFib burden summary is delivered to prescribing physicians summarizing every cardiac event, both asymptomatic and patient activated.

You Must Be Logged In To Post A Comment